Tirzepatide 10mg

Description

Tirzepatide (10mg) – Research Compound

Product Overview: Tirzepatide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Structurally engineered with a 39-amino acid sequence modified with a C20 fatty diacid moiety, it is designed for in vitro laboratory research and analytical studies evaluating multi-receptor metabolic pathways.

Key Specifications:

• Sequence / Structure: 39-amino acid linear peptide chain with C20 fatty diacid side-chain modification

• Purity: ≥98% (HPLC & Mass Spectrometry verified)

• Form: Lyophilized white powder

• Unit Quantity: 10mg per vial

• Storage Conditions: Store at -20°C. Keep protected from moisture and direct light.

Research Context & Potential Applications

In academic and clinical research literature, Tirzepatide is primarily evaluated for its dual agonist activity at GIP and GLP-1 receptors. Key areas of scientific inquiry include:

• Dual Receptor Kinetics: Investigating differential binding affinities, intracellular cAMP generation, and receptor signaling balance across GIP and GLP-1 receptors.

• Glycemic & Metabolic Signaling: Researching insulin secretion kinetics, glucagon suppression mechanics, and cellular sensitivity in specialized cell models.

• Lipid Metabolism & Satiety Pathways: Analyzing downstream gene expression and cellular pathway regulation related to lipid transport, adipocyte biology, and energy balance in vitro.

FOR RESEARCH USE ONLY (RUO)

DISCLAIMER: This product is sold strictly for in vitro scientific laboratory research, analytical testing, and educational purposes. It is NOT intended for human, veterinary, or in vivo use, clinical diagnosis, therapeutic administration, or incorporation into food, drugs, or cosmetics. Any indication of improper handling or non-research application will result in immediate order cancellation and account restriction.